Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Nevodio 5mg tablets

Dexa Medica

Ingredients in every tablet

Nebivolol 5 mg

Each package contains

3 strips of 10 tablets

Dosage form

tablet

Dosage formTablet; plain

Flavour

None

W.H.O. classification

C07A
C07A

A.T.C. Level 1

Anatomical Main group

C - Cardiovascular system
C07A

A.T.C. Level 2

Therapeutic subgroup

C07 - Beta-Adrenergic Blocking Agents
C07A

A.T.C. Level 3

Pharmacological subgroup

C07A - Beta Blocking Agents

Available in

Indonesia
Cambodia

Warnings

Alcohol

SAFE IF PRESCRIBEDThis item is safe for use with alcohol.

Machinery

CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.

Pregnancy

CAUTIONThis item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.

Lactation

NOT RECOMMENDEDThis item is not safe for use during lactation.

Indication

Hypertension: treatment of essential hypertension.
Hypertension
Treatment of essential hypertension

Dosage

18 TO 65 YEARS OLD
The dose is one tablet (5 mg) daily, preferably at the same time of the day. Tablets may be taken with meals. The blood pressure lowering effects becomes evident after 1-2 weeks of treatment. Occasionally, the optimal effect is reached only after 4 weeks.

65 YEARS OLD AND ABOVE
In patients over 65 years, the recommended starting dose is 2.5 mg daily. If needed, the daily dose may be increased to 5 mg. However, in view of the limited experienced in patients above 75 years, caution must be exercised and these patients monitored closely.

UP TO 18 YEARS
No studies have been conducted in children and adolescents. Therefore, use in children and adolescent is not recommended.

COMBINATION WITH OTHER ANTIHYPERTENSIVE AGENTS
Beta-blockers can be used alone or concomitantly with other antihypertensive agents. To date, an additional antihypertensive effect has been observed only when nebivolol 5 mg is combined with hydrochlorothiazide 12.5-25 mg.

PATIENTS WITH HEPATIC IMPAIRMENT
Data in patients with hepatic insufficiency or impaired liver function are limited. Therefore, the use of nebivolol in these patients is contraindicated.